|
Market Closed -
BME
09:05:01 12/08/2026 pm IST
|
After hours 12:00:26 am | |||
| 57.80 EUR | -0.94% |
|
57.92 | +0.22% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +27.43% | 9 | ||||||
| 1,299.56 | +6.96% | 27 | ||||||
| 272.5 | +4.89% | 22 | ||||||
| 275.39 | +10.12% | 28 | ||||||
| 370.31 | +0.38% | 18 | ||||||
| 154.19 | -0.61% | 21 | ||||||
| 211.65 | +32.28% | 22 | ||||||
| 381.59 | -7.9% | 29 | ||||||
| 314.37 | +2.33% | 24 | ||||||
| 157.41 | +15.94% | 27 | ||||||
| 28.64 | +7.6% | 26 | ||||||
| 563.12 | +6.32% | 25 | ||||||
| 66.21 | +4.08% | 24 | ||||||
| 94.28 | +25.04% | 23 | ||||||
| 21.61 | +13.99% | 20 | ||||||
| 9,513.33 | +33.76% | 15 | ||||||
| 6,387.69 | +14.43% | 16 | ||||||
| 56.81 | +16.05% | 18 | ||||||
| 80.33 | +46.14% | 15 | ||||||
| 4.208 | +15.17% | 17 | ||||||
| Average | 1,016.38 | +13.72% | 21 | ||||||
| Weighted average by Cap. | 717.02 | +8.41% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
